| Description | Thalidomide-Piperazine 5-fluoride is a compound developed by synthesizing an E3 ligase ligand-linker conjugate. It incorporates a cereblon ligand derived from Thalidomide and utilizes a linker commonly employed in PROTAC technology. |
| molecular weight | 360.34 |
| Molecular formula | C17H17FN4O4 |
| CAS | 2222114-22-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Hexiang Wang, et al. Degradation of androgen receptor (ar) by conjugation of ar antagonists with e3 ligase ligand and methods of use. WO2021058017A1. |
Thalidomide-Piperazine 5-fluoride
CAS No.: 2222114-22-7
Thalidomide-Piperazine 5-fluoride is a compound developed by synthesizing an E3 ligase ligand-linker conjugate. It incor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.